Your browser doesn't support javascript.
loading
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.
Jackson, Neville; Atar, Dan; Borentain, Maria; Breithardt, Günter; van Eickels, Martin; Endres, Matthias; Fraass, Uwe; Friede, Tim; Hannachi, Hakima; Janmohamed, Salim; Kreuzer, Jörg; Landray, Martin; Lautsch, Dominik; Le Floch, Chantal; Mol, Peter; Naci, Huseyin; Samani, Nilesh J; Svensson, Anders; Thorstensen, Cathrine; Tijssen, Jan; Vandzhura, Victoria; Zalewski, Andrew; Kirchhof, Paulus.
Afiliación
  • Jackson N; Pfizer, Inc., Groton, CT, USA.
  • Atar D; Oslo University Hospital Ulleval and University of Oslo, Oslo, Norway.
  • Borentain M; Bristol-Myers Squibb, Paris, France.
  • Breithardt G; Department of Cardiovascular Medicine, Universitätsklinikum Münster, Münster, Germany Centre for Cardiovascular Sciences, School of Clinical and Experimental Medicine, University of Birmingham and Sandwell and West Birmingham Hospitals National Health Service Trust, Wolfson Drive, Birmingham B15 2TT
  • van Eickels M; Bayer Healthcare, Berlin, Germany.
  • Endres M; Charité-Universitätsmedizin, Berlin, Germany.
  • Fraass U; Amgen, Inc., Munich, Germany.
  • Friede T; Department of Medical Statistics, University Medical Center, Göttingen, Germany DZHK (German Centre for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany.
  • Hannachi H; Merck Inc., Cokesbury, NJ, USA.
  • Janmohamed S; GlaxoSmithKline, Heathrow, London, UK.
  • Kreuzer J; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.
  • Landray M; University of Oxford, Oxford, UK.
  • Lautsch D; Merck Inc., Cokesbury, NJ, USA.
  • Le Floch C; Servier, Paris, France.
  • Mol P; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
  • Naci H; London School of Economics and Political Science, London, UK.
  • Samani NJ; University of Leicester, Leicester, UK.
  • Svensson A; Roche, Inc., Basel, Switzerland.
  • Thorstensen C; Pfizer, Inc., Groton, CT, USA.
  • Tijssen J; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Vandzhura V; Servier, Paris, France.
  • Zalewski A; GlaxoSmithKline, King of Prussia, PA, USA.
  • Kirchhof P; Centre for Cardiovascular Sciences, School of Clinical and Experimental Medicine, University of Birmingham and Sandwell and West Birmingham Hospitals National Health Service Trust, Wolfson Drive, Birmingham B15 2TT, UK Atrial Fibrillation Competence NETwork (AFNET) e.V., Münster, Germany p.kirchhof@
Eur Heart J ; 37(9): 747-54, 2016 Mar 01.
Article en En | MEDLINE | ID: mdl-26077039
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Ensayos Clínicos como Asunto Tipo de estudio: Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur Heart J Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Ensayos Clínicos como Asunto Tipo de estudio: Health_economic_evaluation / Health_technology_assessment / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur Heart J Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos